Rhone-X Study (Protocol number: GR41987)
A 2 year long, phase 3, multi-center, open label extension study to evaluate the long-term safety and tolerability of faricimab in patients with diabetic macular edema.
ClinicalTrials.gov Identifier: NCT04432831
Principal Investigator: Dr Fred Chen
For further information about this study, you may visit the Clinical Trial Registry:
https://clinicaltrials.gov/ct2/show/NCT04432831?term=faricimab&cond=Diabetic+Macular+Edema&cntry=AU&draw=2&rank=1
Or contact the Lions Eye Institute Clinical Trials Office telephone (08) 9381 0750 or email lionsvisiontrials@lei.org.au